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MetalloenzymeIsopenicillin N synthase (IPNS) is a non-heme iron oxidase central to the biosynthesis of b-lactam
antibiotics. IPNS converts the tripeptide d-(L-a-aminoadipoyl)-L-cysteinyl-D-valine (ACV) to isopeni-
cillin N while reducing molecular oxygen to water. The substrate analogue d-(L-a-aminoadipoyl)-L-
cysteinyl-O-methyl-D-threonine (ACmT) is not turned over by IPNS. Epimeric d-(L-a-aminoadipoyl)-
L-cysteinyl-O-methyl-D-allo-threonine (ACmaT) is converted to a bioactive penam product. ACmT
and ACmaT differ from each other only in the stereochemistry at the b-carbon atom of their third
residue. These substrates both contain a methyl ether in place of the isopropyl group of ACV. We
report an X-ray crystal structure for the anaerobic IPNS:Fe(II):ACmT complex. This structure reveals
an additional water molecule bound to the active site metal, held by hydrogen-bonding to the ether
oxygen atom of the substrate analogue.
 2013 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Isopenicillin N synthase (IPNS) is a member of the non-heme
iron oxidase family of enzymes [1–3]. IPNS uses an iron(II) cofactor
and molecular oxygen to catalyse cyclisation of its tripeptide sub-
strate d-(L-a-aminoadipoyl)-L-cysteinyl-D-valine (ACV, 1) to bicy-
clic isopenicillin N (IPN, 2), the central step in penicillin
biosynthesis (Scheme 1) [4]. IPNS catalysis has been extensively
studied using spectroscopy [5–8], crystallography [9–11], compu-
tational modeling [12,13], and turnover experiments with sub-
strate analogues [4,14]. It is generally agreed that the IPNS
reaction cycle proceeds via initial b-lactam formation and a high-
valent iron-oxo intermediate [11,15].
A diverse array of tripeptide analogues have been incubated
with IPNS in the parallel effort to access new antibiotic structures
and characterize the enzyme mechanism [4,14]. The ACV analogued-(L-a-aminoadipoyl)-L-cysteinyl-O-methyl-D-threonine (ACmT, 3)
contains a methyl ether in place of the valinyl isopropyl group of
ACV. ACmT 3 is not turned over by IPNS but the epimeric tripeptide
d-(L-a-aminoadipoyl)-L-cysteinyl-O-methyl-D-allo-threonine (AC-
maT 4) does react, and is converted by IPNS to 2-a-methoxy-2-b-
methylpenam 5 (Scheme 2a) [16,17]. Penam 5 has antibiotic activ-
ity comparable to isopenicillin N 2 [16].
This result stands in contrast to incubation experiments with
the isosteric tripeptides that contain D-isoleucine (ACI, 6) and D-
allo-isoleucine (ACaI, 7) (Scheme 2b). ACI 6 and ACaI 7 are both
cyclized to penicillin products by IPNS, with retention of conﬁgu-
ration in the C–S bond-forming step [18,19]. However neither of
the corresponding sulfur-containing compounds AC-D-thioisoleu-
cine (ACtI, 8) and AC-D-thio-allo-isoleucine (ACtaI, 9) is turned
over by the enzyme [14,20]. It was concluded in 1989 that the
difference between the two series (3 and 4 on the one hand, 6
and 7 on the other) ‘‘must derive from some property of the
methoxy function,’’ and proposed that ‘‘a hydrogen bond between
the methoxy group and an active site group restricts rotation
around C(2)–C(3) in the intermediate . . . so the [intermediate] de-
rived from the allo-threonine peptide can be cyclised, but that de-
rived from the threonine [peptide] is restrained in a conformation
in which the b-hydrogen atom cannot be attacked by the active
species’’ [21].
Scheme 1. The IPNS-catalysed reaction: conversion of the linear tripeptide ACV 1 to bicyclic IPN 2, biosynthetic progenitor of all penicillin and cephalosporin antibiotics (L-
AA = d-(L-a-aminoadipoyl)).
Scheme 2. (a) The reaction of IPNS with the epimeric substrate analogues ACmT 3 and ACmaT 4: ACmT 3 is not turned over by the enzyme, while ACmaT 4 gives a bioactive
penam 5. (b) Structures of the isosteric tripeptides ACI 6, ACaI 7, ACtI, 8 and ACtaI, 9 (L-AA = d-(L-a-aminoadipoyl)).
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strate complex [10] paint a detailed structural picture of the en-
zyme active site. Time-resolved studies using high-pressure
oxygenation to initiate reaction within crystalline IPNS have en-
abled step-by-step elucidation of the reaction mechanism on a
structural level [11,22–25], while structures of the enzyme with
ACV analogues reveal a range of binding modes and the interplay
between steric and electronic effects at the IPNS active site [26–
32]. Seeking. a structural explanation for the failure of ACmT 3 to
react with IPNS, we have crystallised the protein with this sub-
strate analogue and solved the crystal structure of the IPNS:-
Fe(II):ACmT complex.
2. Materials and methods
2.1. Synthesis of d-(L-a-aminoadipoyl)-L-cysteinyl-O-methyl-D-
threonine 3
D-Threonine 10 (Aldrich) was N-Boc-protected [33] then con-
verted to N-Boc-O-methyl-D-threonine 11 using sodium iso-prop-
oxide and methyl iodide in THF as described by Chen andScheme 3. Synthesis of target tripeptide 3; (i) NaOH, H2O/tBuOH, (Boc)2O, rt, 23 h, 100%;
Et2O, rt, 55% (over 2 steps); (v) EDCI, HOBt, Et3N, DCM, rt, 20 h, 100%; (vi) TFA, anisole,Benoiton (Scheme 3) [34]. Although the percentage conversion in
this etheriﬁcation reaction is low (24–32% in our hands) unreacted
starting material (45–49%) is readily recovered and recycled; the
product 11 and residual starting material were isolated together
after work-up and could be separated by partitioning the resultant
oil between small volumes of DCM and water. N-Boc-O-methyl-D-
threonine 11was isolated from the DCM phase and further puriﬁed
by crystallisation from chloroform.
The Boc group was removed using toluenesulfonic acid [35] and
the resulting carboxylic acid converted to the benzhydryl ester 12
using diphenyldiazomethane [36] (Scheme 3). Protected amino
acid 12was coupled to previously reported dipeptide 13 [23] using
1-(3-dimethylaminopropyl)-3-ethylcarbodiimide (EDCI) and 1-
hydroxybenzotriazole hydrate (HOBt) [37] under standard condi-
tions to give protected tripeptide 14. Global deprotection with tri-
ﬂuoroacetic acid [38] gave the tripeptide 3 which was collected as
the triﬂuoroacetate salt by precipitation from ether. Puriﬁcation by
reversed-phase HPLC (octadecylsilane 250  10 mm; k = 254 nm, 5
AUFS; 4 mL/min, 10 mM NH4HCO3 in water/methanol as eluant:
running time 0–5 min, 0% methanol; 5–12 min, gradient of 0–
25% methanol; 13–18 min, 2.5% methanol; 18–20 min 0% metha-(ii) NaOiPr, CH3I, THF, 0 C, 48 h, 32%; (iii) TsOH, toluene, 40 C; (iv) Ph2CN2, CH3CN/
reﬂux, 30 min, 100%; RP-HPLC.
Table 1
Data collection and statistics.
IPNS:Fe(II):ACmT
X-ray source Rigaku rotating anode
Wavelength (Å) 1.5418
PDB acquisition code 3zoi
Resolution (Å) 1.81
Space group P212121
Unit Cell Dimensions (a Å, b Å, c Å) 46.48, 70.79, 100.51
Resolution shell (Å) 21.01–1.81 1.91–1.81
Total number of reﬂections 92909 10764
Number of unique reﬂections 27150 3414
Completeness (%) 98.2 92.1
Average I/r(I) 14.3 2.9
Rmerge (%)a 6.4 33.5
Rmeas (%)b 7.6 40.6
Rcryst (%)c 16.2
Rfree (%)d 20.2
RMS deviatione 0.020 (1.8)
Average B factors (Å2)f 18.6 21.0 16.3 24.6
Number of water molecules 233
a Rmerge ¼
P
j
P
hjIh;j—hIhij=
P
j
P
hhIhi  100.
b Rmeas ¼
P
hkl
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
N=ðN  1Þp PijIiðhklÞ  IðhklÞj=
P
hkl
P
l IiðhklÞ  100 [54,55].
c Rcryst ¼
P jjFobsj  jFcalcjj=
P jFobsj  100.
d Rfree = based on 5% of the total reﬂections.
e RMS deviation from ideality for bonds (followed by the value for angles).
f Average B factors in order: main chain; side-chain; substrate and iron; solvent (water).
Fig. 1. Stereo view of the active site of the anaerobic IPNS:Fe(II):ACmT complex, showing (i) a 2mFoDfc electron density map (cyan) contoured at 1.5r around the substrate
ACmT; and (ii) a mFoDFc omit map (pink) contoured at 4r around key water molecules (calculated from a model in which all waters were removed, random noise (0.2 Å
max) added to remaining coordinates, then re-reﬁned). Figure generated using ccp4 mg [53].
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phine hydrochloride for 20 min prior to injection onto the HPLC
column to reduce any cysteine disulﬁdes [39]) gave tripeptide 3
as a ﬁne white powder; Rt 11 min 40 s; dH (500 MHz, D2O): 1.05
(3H, d, J 6.5, CHCH3), 1.52–1.70 (2H, m, +H3NCHCH2CH2CH2),
1.73–1.88 (2H, m, +H3NCHCH2CH2CH2), 2.33 (2H, t, J 7.5, +H3-
NCHCH2CH2CH2), 2.82 (1H, A of ABX, JAB 14.0, JAX 7.5 Hz, 1 of CH2-
SH), 2.87 (1H, B of ABX, JBA 14.0, JBX 5.5 Hz, 1 of CH2SH), 3.23 (3H, s,
CH3O), 3.65 (1H, m, +H3NCHCH2CH2CH2), 3.86 (1H, qd, J 6.5, 3.5 Hz,
CHOCH3), 4.13 (1H, d, J 3.5 Hz, NHCHCHOCH3), 4.52 (1H, X of ABX,
JXA 7.5, JXB 5.5 Hz, NHCHCH2SH).
2.2. Crystallography and structure determination
Crystals of the IPNS:Fe(II):ACmT complex were grown under
anaerobic conditions as previously reported (1.8–2.0 M lithium
sulfate and 100 mM Tris/HCI, pH 8.5) [40,41]. Crystals for X-ray dif-
fraction were selected using a light microscope, removed from the
anaerobic environment and exchanged into cryoprotectant buffer(1:1 mixture of well buffer and saturated lithium sulfate in 40%
v/v glycerol), then ﬂash-frozen in liquid nitrogen [40,41].
Data were collected at 100 K using Cu-Ka radiation from a Rig-
aku rotating anode generator and a MAR Research 300 mm image
plate detector at The Department of Molecular Biophysics, Oxford
University. The temperature was maintained at 100 K using an Ox-
ford Cryosystems Cryostream. Data were processed using DENZO
[42], MOSFLM [43] and the CCP4 suite of programs [44], then re-
ﬁned using REFMAC5 [45] and Coot for model building [46]. Initial
phases were generated using co-ordinates for the protein from the
previously published IPNS:Fe(II):ACV structure [10], and manual
rebuilding of protein side-chains was performed as necessary.
The active site iron atom and water molecules were modeled in
during an early stage of the reﬁnement process. Electron density
for ACmT was clearly visible throughout, and modeled in sequen-
tially at an advanced stage of reﬁnement. Crystallographic coordi-
nates and structure factors for the IPNS:Fe(II):ACmT complex have
been deposited in the Protein Data Bank (PDB) under accession
number 3zoi.
Fig. 2. Close-up of the ligands around iron(II) in the IPNS active site: (a) IPNS:Fe(II):ACV complex; and (b) IPNS:Fe(II):ACmT complex. Key water ligands are shown: #713
opposite His214 in the ACV complex, compared to #2178 (opposite His214) and #2173 (opposite Asp216) in the ACmT structure. Figure generated using ccp4 mg [53].
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3.1. Structure of the IPNS:Fe(II):ACmT complex
The X-ray crystal structure of the anaerobic IPNS:Fe(II):ACmT
complex was solved to 1.81 Å resolution (Table 1, Figs. 1 and 2).
This structure reveals an interesting binding arrangement around
iron. The familiar facial triad of the protein-derived ligands is in
place: the side-chains of His214, Asp216 and His270 ligate to iron,
as seen previously with IPNS and other non-heme iron enzymes
[1,9,10,47]. ACmT is held in the enzyme active site in a similar
way to the native substrate [10]: via a salt bridge to the amin-
oadipoyl amino group, hydrogen bonds to the carboxylate of the
mThr residue, and ligation of the cysteinyl thiolate to iron in the
site opposite His270. However in contrast to the IPNS:Fe(II):ACV
complex, there are two water ligands bound to the metal with
ACmT, meaning that iron is hexacoordinate. In the complex of IPNS
with its natural substrate ACV (Fig. 2a) [10] and complexes with
substrate analogues containing third residues of a similar size
[22,24,48], only one water ligand is present at iron, opposite
His214 (#713 in Fig. 2a). In addition to this usual water ligand at
iron (#2178 in Fig. 2b), the ACmT complex contains a second water
molecule bound in the site trans to Asp216 (#2173). This second
water ligand is 2.36 Å from the iron and 2.41 Å from the methoxy
oxygen of the mThr residue, ideally placed to hydrogen bond to it
(Fig. 2b).
In the IPNS:Fe(II):ACV structure and related complexes [10,22],
the site trans to Asp216 is occupied by the side-chain of the sub-
strate D-valine residue: iron is pentacoordinate with the valinyl
isopropyl group sitting within van der Waals contact of the metal.
This interaction effectively reserves the sixth iron binding site for
the co-substrate molecular oxygen [10]. Hexacoordinate iron has
previously been observed in IPNS complexes: (i) with analogues
that incorporate a methyl sulﬁde in their third residue (e.g. AC-D-
thia-allo-isoleucine (ACtaI, 9) [20] and AC-D-methionine [49]), in
which the afﬁnity of sulfur for iron means that the sulﬁde S coor-
dinates to the metal; (ii) with smaller substrate analogues (e.g.
AC-Gly and AC-D-Ala,[28] AC-D-a-aminobutyrate [26], AC-D-vinyl-
glycine [23] and the dipeptide d-L-a-aminoadipoyl-L-homocysteine
(AhC) [50]), where the smaller side-chain leaves room for a
second water ligand to bind to iron opposite Asp216; and (iii) with
LLL-conﬁgured substrates (e.g. AC-L-hexaﬂuorovaline [51] and
AC-L-2-amino-3,3-dideuteriobutyrate [52]), where the different
substrate stereochemistry permits an additional water ligand at
iron.ACmT 3 is unusual in that despite its size, this analogue fails to
exclude water from the iron binding site opposite Asp216. ACmT 3
is isosteric with ACI 6 and thus more sterically demanding than the
natural substrate ACV, yet the IPNS:Fe(II):ACmT complex still
incorporates the extra water ligand at iron. We propose that this
arrangement arises due to the greater hydrophilicity of the mThr
side-chain relative to Val, and the capacity for hydrogen bonding
between the methoxy group of 3 and water ligand #2173. Further,
we postulate that the bonding interactions between this water li-
gand, iron and the mThr methoxy group, and the greater bulk of
the mThr side-chain relative to the native substrate, combine to
exclude the cosubstrate O2 from the active site of the IPNS:-
Fe(II):ACmT complex.4. Conclusions
Ligation of water molecule #2173 in the oxygen binding site of
the IPNS:Fe(II):ACmT complex provides a possible structural expla-
nation for the failure of IPNS to turnover ACmT 3. Held by hydro-
gen bonds to the substrate methoxy group and ligated to iron
trans to Asp216, this water molecule and the mThr side-chain
may prevent oxygen entry and thus block turnover before reaction
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